This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Drugmakers fail to stop UK intervention in EU pay-for-delay court case

( November 13, 2017, 11:28 GMT | Official Statement) -- MLex Summary: German pharmaceutical company Merck, Generics (UK), India-based Sun Pharmaceutical Industries (formerly Ranbaxy Laboratories) and Ranbaxy (UK), have failed to stop the UK government from intervening in proceedings before the EU's highest court, over an antitrust fine of 146 million euros that was imposed on the drugmakers for delaying the sale of cheaper versions of a blockbuster depression drug.The court order follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections